Pregabalin Capsule
Product Images NDC 71335-1762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351762)

Label (Lbl713351762)
This is a medicine package for a generic version of Lyrica 25mg capsules, packaged by Bryant Ranck Prepack. The package contains 30 capsules and should be stored at room temperature. The NDC number is 7133517621. There is a warning to keep all drugs out of reach of children.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Equation 1)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

Study Phn 2 (Pregabalin Image 4)
The text seems to be a table showing the percentage improvement in pain of patients based on the dosage of Pregabalin they received, compared to a placebo. However, the text is not very clear, making it difficult to read and understand properly.*
FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Epilepsy Study (Pregabalin Image 6)

FDA Label Image

Studies E1, E2, And E3 (Pregabalin Image 7)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

Fibromyalgia Study F1 (Pregabalin Image 8)
The text provides information on the percentage of patients who improved their pain levels from baseline after taking different doses of Pregabalin and Fiacsto. The table shows that patients taking 450mg or 300mg daily doses of Pregabalin saw a higher percentage of improvement in pain levels compared to those taking 150mg or 0mg of Pregabalin. However, no specific data is provided on the actual percentage of improvement.*
FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.